MS: Busting the Myths
July 27, 2023 | Treatments
Image: myriam-zilles-unsplash Today, the World Health Organisation (WHO) added three Disease Modifying Treatments (DMTs) for Multiple Sclerosis (MS) onto its Essential Medicines List for the first time. Addressing the global MS movement, Prof Mai Sharawy, Chair of the Board of […]
June 1, 2023 | Treatments, Webinar
Multiple Sclerosis New Zealand (MSNZ) and the New Zealand Multiple Sclerosis Research Trust (NZMSRT) are pleased to share with you our aHSCT for MS in New Zealand webinar that marked World MS Day on 30 May. Autologous haematopoetic stem cell […]
May 24, 2023 | Education, Event, Life with MS, Treatments, Webinar
Multiple Sclerosis New Zealand (MSNZ) and the New Zealand Multiple Sclerosis Research Trust (NZMSRT) are pleased to invite you to our webinar to mark World MS Day on 30 May. Autologous haematopoetic stem cell transplant (aHSCT) has captured the interest […]
November 16, 2022 | Advocacy, Funding, Treatments
At the August 2022 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC), Multiple Sclerosis NZ (MSNZ) made a submission in support of the funding of Siponimod (Mayzent) for Secondary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested further advice from the […]
November 16, 2022 | Advocacy, Covid-19, Treatments
Important notice for MS patients regarding EvusheldTM. EvusheldTM is a pre-exposure prophylaxis, which has shown positive results for reducing the impacts of COVID-19 on those who may lowered immunity against COVID 19 due to their MS treatments. Evusheld is NOT […]